RAVASIO, R.; VITI, R.; ROSCINI, A. S. Cost per responder for vedolizumab and ustekinumab in Crohn’s disease patients after failure of TNF-α inhibitors in Italy. AboutOpen, [S. l.], v. 10, n. 1, p. 13–21, 2023. DOI: 10.33393/ao.2023.2515. Disponível em: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2515. Acesso em: 23 nov. 2024.